Search Results - "Clarke, Deborah L"

Refine Results
  1. 1

    The epithelium in idiopathic pulmonary fibrosis: breaking the barrier by Camelo, Ana, Dunmore, Rebecca, Sleeman, Matthew A, Clarke, Deborah L

    Published in Frontiers in pharmacology (10-01-2014)
    “…Idiopathic pulmonary fibrosis is a progressive disease of unknown etiology characterized by a dysregulated wound healing response that leads to fatal…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Long Non-coding RNAs Are Central Regulators of the IL-1β-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts by Hadjicharalambous, Marina R, Roux, Benoit T, Feghali-Bostwick, Carol A, Murray, Lynne A, Clarke, Deborah L, Lindsay, Mark A

    Published in Frontiers in immunology (11-12-2018)
    “…There is accumulating evidence to indicate that long non-coding RNAs (lncRNAs) are important regulators of the inflammatory response. In this report, we have…”
    Get full text
    Journal Article
  4. 4

    Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis by Hadjicharalambous, Marina R., Roux, Benoit T., Csomor, Eszter, Feghali-Bostwick, Carol A., Murray, Lynne A., Clarke, Deborah L., Lindsay, Mark A.

    Published in Scientific reports (15-04-2019)
    “…Phenotypic changes in lung fibroblasts are believed to contribute to the development of Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal lung…”
    Get full text
    Journal Article
  5. 5

    Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes by Clarke, Deborah L, Carruthers, Alan M, Mustelin, Tomas, Murray, Lynne A

    Published in Fibrogenesis & tissue repair (26-11-2013)
    “…Repairing damaged tissues is an essential homeostatic mechanism that enables clearance of dead or damaged cells after injury, and the maintenance of tissue…”
    Get full text
    Journal Article
  6. 6

    Development of a mouse model mimicking key aspects of a viral asthma exacerbation by Clarke, Deborah L, Davis, Nicola H E, Majithiya, Jayesh B, Piper, Sian C, Lewis, Arthur, Sleeman, Matthew A, Corkill, Dominic J, May, Richard D

    Published in Clinical science (1979) (01-04-2014)
    “…Viral respiratory tract infections are known triggers of asthma exacerbations in both adults and children. The current standard of care, inhaled CS…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis? by Clarke, Deborah L, Murray, Lynne A, Crestani, Bruno, Sleeman, Matthew A

    Published in Pharmacology & therapeutics (Oxford) (01-01-2017)
    “…Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial pneumonia of unknown cause, characterised by progressive worsening in lung function and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    EP4 receptor as a new target for bronchodilator therapy by Buckley, James, Birrell, Mark A, Maher, Sarah A, Nials, Anthony T, Clarke, Deborah L, Belvisi, Maria G

    Published in Thorax (01-12-2011)
    “…Asthma and chronic obstructive pulmonary disease are airway inflammatory diseases characterised by airflow obstruction. Currently approved bronchodilators such…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kB and AP-1 by Sutcliffe, Amy M, Clarke, Deborah L, Bradbury, Dawn A, Corbett, Lisa M, Patel, Jamie A, Knox, Alan J

    Published in British journal of pharmacology (01-06-2009)
    “…Background and purpose: Endothelin-1 (ET-1) is implicated in airway inflammation in asthma, but the mechanisms of its effects are poorly understood. We studied…”
    Get full text
    Journal Article
  16. 16

    Transcriptional regulation of monocyte chemotactic protein‐1 release by endothelin‐1 in human airway smooth muscle cells involves NF‐κB and AP‐1 by Sutcliffe, Amy M, Clarke, Deborah L, Bradbury, Dawn A, Corbett, Lisa M, Patel, Jamie A, Knox, Alan J

    Published in British journal of pharmacology (01-06-2009)
    “…Background and purpose:  Endothelin‐1 (ET‐1) is implicated in airway inflammation in asthma, but the mechanisms of its effects are poorly understood. We…”
    Get full text
    Journal Article
  17. 17

    Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE 2 inhibits the release of GM‐CSF by Clarke, Deborah L, Belvisi, Maria G, Catley, Matthew C, Yacoub, Magdi H, Newton, Robert, Giembycz, Mark A

    Published in British journal of pharmacology (30-01-2009)
    “…The prostanoid receptor(s) on human airways smooth muscle (HASM) cells that mediates the inhibitory effect of PGE 2 on interleukin (IL)‐1 β ‐induced…”
    Get full text
    Journal Article
  18. 18

    Are mast cells instrumental for fibrotic diseases? by Overed-Sayer, Catherine, Rapley, Laura, Mustelin, Tomas, Clarke, Deborah L

    Published in Frontiers in pharmacology (2014)
    “…Idiopathic pulmonary fibrosis (IPF) is a fatal lung disorder of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix…”
    Get full text
    Journal Article
  19. 19

    Lipid metabolites as regulators of airway smooth muscle function by Clarke, Deborah L, Dakshinamurti, Shyamala, Larsson, Anna-Karin, Ward, Jane E, Yamasaki, Akira

    Published in Pulmonary pharmacology & therapeutics (01-10-2009)
    “…Abstract Compelling evidence identifies airway smooth muscle (ASM) not only as a target but also a cellular source for a diverse range of mediators underlying…”
    Get full text
    Journal Article
  20. 20